In vitro and in vivo binding of toremifene and its metabolites in rat uterus.
The in vitro binding affinities of toremifene (TOR), 4-hydroxy toremifene (4-OH-TOR) and several other metabolites for the rat uterine cytosolic estrogen receptor were compared with those of tamoxifen (TAM) and 4-hydroxy tamoxifen (4-OH-TAM). Only small differences were observed and the binding affinities of both 4-hydroxy metabolites were similar to that of estradiol (E2). Uterine uptake and subcellular distribution of [3H]TOR and [3H]TAM were then compared at 1, 8 and 72 h after administration to castrated rats. The uptake and retention of both antiestrogens were similar at all times. In each case the amount of nuclear bound radioactivity declined to low levels at 8 and 72 h but the ratios of 4-OH-TAM/TAM and 4-OH-TOR/TOR determined by HPLC analysis increased dramatically at 72 h. The level of radioactivity in both plasma and uterine cytosol at 72 h was significantly higher following [3H]TAM administration. However, most of the radioactivity appeared to be in a conjugated form since it was not extractable with solvent. Finally, the ability of prior administration of each antiestrogen (100 mg/kg) to block uterine [3H]estradiol uptake was examined at 3 and 7 days. It was found that uterine wet weights were higher than control one week after administration of both compounds. Prior administration of TOR increased nuclear uptake of [3H]E2 whereas TAM had no effect. The results of these experiments suggest that toremifene and tamoxifen have very similar in vitro and in vivo binding properties but differences in metabolism exist that may be important.
Simberg
N H
NH
Department of Physiology, University of Turku, Finland.
Murai
J T
JT
Siiteri
P K
PK
D000818:Animals; D004958:Estradiol / Q000493:pharmacokinetics; D004965:Estrogen Antagonists / Q000097:blood / Q000378:metabolism* / Q000493:pharmacokinetics; D005260:Female; D007700:Kinetics; D051381:Rats; D011919:Rats, Inbred Strains; D013629:Tamoxifen / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics; D017312:Toremifene; D014316:Tritium; D014599:Uterus / Q000378:metabolism*
D004965:Estrogen Antagonists; D013629:Tamoxifen; D014316:Tritium; C016601:afimoxifene; D004958:Estradiol; D017312:Toremifene